Concepedia

Joe Gootenberg

JG

Statistics

Publications

2

Citations

625

H-Index

2

Active since

2007

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Joe Gootenberg is an author at United States Food and Drug Administration specializing in medicine, oncology, and fda drug regulation.

Publications per year

2007–2007

2

Publications

2

FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer

Martin H. Cohen, Joe Gootenberg, Patricia Keegan et al. · The Oncologist · 2007 · 400 citations

, , +14

FDA Drug Approval Summary: Bevacizumab Plus FOLFOX4 as Second-Line Treatment of Colorectal Cancer

Martin H. Cohen, Joe Gootenberg, Patricia Keegan et al. · The Oncologist · 2007 · 225 citations · Full text

, , +15

1–2 of 2